Kestra Advisory Services, LLC Acadia Pharmaceuticals Inc Transaction History

Kestra Advisory Services, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$17.8 - $25.65 $149,573 - $215,536	8,403 New	8,403 $201,000
Q2 2022 Aug 12, 2022	SELL	$13.01 - $27.22 $111,833 - $233,983	-8,596 Closed	0 $0
Q1 2022 Apr 26, 2022	BUY	$20.94 - $27.5 $180,000 - $236,390	8,596 New	8,596 $0
Q4 2021 Jan 20, 2022	SELL	$16.79 - $27.09 $175,254 - $282,765	-10,438 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$15.78 - $24.77 $2,398 - $3,765	-152 Reduced 1.44%	10,438 $0
Q2 2021 Jul 28, 2021	SELL	$19.4 - $27.42 $20,777 - $29,366	-1,071 Reduced 9.18%	10,590 $0
Q1 2021 May 10, 2021	SELL	$25.02 - $54.99 $98,628 - $216,770	-3,942 Reduced 25.26%	11,661 $0
Q4 2020 Jan 20, 2021	BUY	$41.04 - $56.79 $112,983 - $156,342	2,753 Added 21.42%	15,603 $838 Million
Q3 2020 Nov 12, 2020	BUY	$36.42 - $57.0 $467,997 - $732,450	12,850 New	12,850 $530 Million

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Advisory Services, LLC with notifications on news.